Off-label use of the expensive orphan drug eculizumab in France 2009–2013 and the impact of literature: focus on the transplantation field
Crossref DOI link: https://doi.org/10.1007/s00228-016-2027-z
Published Online: 2016-02-26
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Castañeda-Sanabria, Johann
Hajage, David
Le Jouan, Melisande
Perozziello, Anne
Tubach, Florence
Funding for this research was provided by:
Inserm CIC-EC 1425
Text and Data Mining valid from 2016-02-26